文献
J-GLOBAL ID:201502209322127150
整理番号:15A1096721
イマチニブとスニチニブ治療後の進行性消化管間質腫瘍のためのレゴラフェニブ: 第三相GRID試験において日本人患者を評価するサブグループ分析
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial
著者 (8件):
KOMATSU Yoshito
(Hokkaido Univ. Hospital, Cancer Center, Kita 14 Nishi 5, Kita-ku, 060-8648, Sapporo, Hokkaido, JPN)
,
DOI Toshihiko
(National Cancer Center Hospital East, Kashiwa, JPN)
,
SAWAKI Akira
(Nagoya Second Red Cross Hospital, Dep. of Oncology and Gastroenterology, Nagoya, JPN)
,
KANDA Tatsuo
(Niigata Univ. Graduate School of Medical and Dental Sciences, Div. of Digestive and General Surgery, Niigata, JPN)
,
YAMADA Yasuhide
(National Cancer Center Hospital, Gastrointestinal Oncology Div., Tokyo, JPN)
,
KUSS Iris
(Bayer Pharma AG, Global Clinical Dev., Oncology, Ophthalmology and Neurology, Berlin, DEU)
,
DEMETRI George D.
(Harvard Medical School, Ludwig Cancer Center, Dana-Farber Cancer Inst., Boston, MA, USA)
,
NISHIDA Toshirou
(National Cancer Center Hospital East, Dep. of Surgery, Kashiwa, JPN)
資料名:
International Journal of Clinical Oncology
(International Journal of Clinical Oncology)
巻:
20
号:
5
ページ:
905-912
発行年:
2015年10月
JST資料番号:
L3966A
ISSN:
1341-9625
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)